tiprankstipranks
Trending News
More News >
Anixa Biosciences (ANIX)
NASDAQ:ANIX
US Market

Anixa Biosciences (ANIX) Income Statement

Compare
505 Followers

Anixa Biosciences Income Statement

Last quarter (Q4 2025), Anixa Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Anixa Biosciences's net income was $-2.69M. See Anixa Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 210.00K$ 0.00$ 512.00K
Gross Profit
$ -36.00K$ -37.00K$ 49.00K$ 0.00$ 127.00K
Operating Expenses
$ 11.66M$ 13.83M$ 11.06M$ 13.88M$ 13.26M
Depreciation and Amortization
$ 36.00K$ 37.00K$ 46.00K$ 42.00K$ 59.86K
EBITDA
$ -11.70M$ -12.66M$ -10.96M$ -13.73M$ -13.08M
Operating Income
$ -11.70M$ -13.83M$ -11.01M$ -13.88M$ -13.14M
Other Income/Expenses
$ 673.00K$ 1.13M$ 1.08M$ 104.00K$ 7.77K
Pretax Income
$ -11.03M$ -12.70M$ -9.93M$ -13.77M$ -13.13M
Net Income
$ -10.93M$ -12.55M$ -9.81M$ -13.60M$ -12.95M
Per Share Metrics
Basic EPS
$ -0.34$ -0.39$ -0.32$ -0.45$ -0.45
Diluted EPS
$ -0.34$ -0.39$ -0.32$ -0.45$ -0.45
Weighted Average Shares Outstanding
32.45M 31.90M 30.98M 30.37M 28.58M
Weighted Average Shares Outstanding (Diluted)
32.45M 31.90M 30.98M 30.37M 28.58M
Currency in USD

Anixa Biosciences Earnings and Revenue History